Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma]H Tateishi, Y Hasuike, M Kinuta, et al.
International Journal of Oncology|May 12, 2011
Comparison of response to 5'-deoxy-5-fluorouridine therapy alone and in combination with tamoxifen or medroxyprogesterone acetate in advanced and recurrent breast-cancerE Yayoi, Y Takatsuka, Y Maeura, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinomaY Hasuike, J Okamura, J Furukawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1988
[Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--third report. Clinical Study Group of Adriamycin for Breast Cancer in Japan]E Yayoi, T Terasawa, H Koyama, et al.
Japanese Journal of Clinical Oncology|December 1, 1989
Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple DischargeT Mori, H Inaji, M Higashiyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1983
[Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--second report]K Sakai, E Yayoi, T Terasawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|March 1, 1988
[A case of remarkable regression of a colonic cancer involving metastasis to the liver as a result of FT-207 treatment]S Nishibe, M Naoi, H Maruyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Combination of transarterial chemoembolization and endocrine therapy for liver metastases of breast cancer]E Yayoi, M Nishihara, H Miyoshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basisS J Kim, E Shiba, T Kobayashi, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
A prospective study on the prognostic significance of urokinase-type plasminogen activator levels in breast cancer tissueE Shiba, S J Kim, T Taguchi, et al.
Pageof 5